SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-149776
Filing Date
2021-12-15
Accepted
2021-12-15 07:00:47
Documents
15
Period of Report
2021-12-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2135455d1_8k.htm   iXBRL 8-K 30237
2 EXHIBIT 99.1 tm2135455d1_ex99-1.htm EX-99.1 9812
6 GRAPHIC image_001.jpg GRAPHIC 4392
7 GRAPHIC image_002.jpg GRAPHIC 4392
  Complete submission text file 0001104659-21-149776.txt   232745

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA kprx-20211213.xsd EX-101.SCH 3204
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE kprx-20211213_lab.xml EX-101.LAB 34594
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kprx-20211213_pre.xml EX-101.PRE 22723
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2135455d1_8k_htm.xml XML 3725
Mailing Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105
Business Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105 (781) 788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36672 | Film No.: 211493071
SIC: 2834 Pharmaceutical Preparations